LTC004
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LTC004, covering 2024-03-21 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy [Phase 2]